Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 03, 2020

SELL
$54.82 - $64.09 $229,092 - $267,832
-4,179 Closed
0 $0
Q1 2020

Apr 27, 2020

SELL
$46.4 - $67.43 $9,280 - $13,486
-200 Reduced 4.57%
4,179 $233,000
Q4 2019

Jan 30, 2020

BUY
$49.21 - $64.19 $215,490 - $281,088
4,379 New
4,379 $281,000
Q2 2019

Aug 05, 2019

SELL
$44.62 - $49.34 $213,462 - $236,042
-4,784 Closed
0 $0
Q4 2018

Jan 31, 2019

SELL
$48.76 - $63.23 $12,238 - $15,870
-251 Reduced 4.99%
4,784 $249,000
Q3 2018

Oct 31, 2018

SELL
$55.19 - $62.25 $29,250 - $32,992
-530 Reduced 9.52%
5,035 $313,000
Q2 2018

Aug 01, 2018

BUY
$50.53 - $62.98 $26,780 - $33,379
530 Added 10.53%
5,565 $308,000
Q3 2017

Nov 02, 2017

BUY
$55.23 - $63.74 $278,083 - $320,930
5,035
5,035 $321,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sonata Capital Group Inc Portfolio

Follow Sonata Capital Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sonata Capital Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sonata Capital Group Inc with notifications on news.